national congress 10 - 13 october 2017 mico congress ... · 10 - 13 october 2017 mico congress...

National Congress Italian Society of Interventional Cardiology

The Peripheral Course By and For Interventional Cardiologists

10 - 13 October 2017 MiCo Congress Centre

Milano - Italy

38°

Nat

iona

l Con

gres

s It

alia

n So

ciet

y of

Inte

rven

tion

al C

ardi

olog

y -

10 -

13

Oct

ober

201

7 M

iCo

Cong

ress

Cen

tre

Mila

no -

Ital

y

PRELIMINARY PROGRAMME

TM 1


SCIENTIFIC COMMITTEE38th GISE NATIONAL CONGRESS PRESIDENT

Alfredo Marchese (Bari)

COORDINATORSPiera Capranzano (Catania)

Battistina Castiglioni (Varese)Bernardo Cortese (Milano)Leonardo De Luca (Tivoli)Antonino Nicosia (Ragusa)Francesco Saia (Bologna)

Giuseppe Tarantini (Padova)Daniela Trabattoni (Milano)

START-UP AND INNOVATIONBernardo Cortese (Milano)Alberto De Caterina (Pisa)

GISE YOUNGAlessio Mattesini (Firenze)Elisabetta Ricottini (Roma)

LOOKING ABROADDominick Angiolillo (Jacksonville)

Emanuele Barbato (Aalst)Salvatore Brugaletta (Barcellona)

Marco Roffi (Zurigo)Marco Valgimigli (Berna)

EXECUTIVE MEMBERSMarco Basile (Bari)

Nedy Brambilla (Milano)Paolo Calabrò (Napoli)

Marco Caruso (Palermo)Micaela Conte (Latina)

Giuseppe De Luca (Novara)Enrico Fabris (Trieste)Luca Favero (Treviso)

Dionigi Fischetti (Lecce)Andrea Gagnor (Torino)

Gennaro Galasso (Salerno)Francesco Greco (Cosenza)

Claudio Larosa (Andria)Azeem Latib (Milano)

Fabio Minicucci (Napoli)Francesco Meucci (Firenze)

Vittorio Monda (Napoli)Marco Mojoli (Padova)

Eliano Navarese (Milano)Giampaolo Niccoli (Roma)

Emanuela Piccaluga (Milano)Italo Porto (Roma)

Stefano Rigattieri (Roma)Andrea Rognoni (Novara)

Paolo Sbarzaglia (Cotignola)Nicola Signore (Bari)

Carmen Spaccarotella (Catanzaro)

PCR PERIPHERAL SCIENTIFIC BOARDCourse Director

Alberto Cremonesi (Italy)

Course co-Directors Carlo Cernetti (Italy)

Ömer Göktekin (Turkey) Antonino Nicosia (Italy)

Antoine Sauguet (France)

2


2 33

GISE EXECUTIVE COMMITTEE

PRESIDENTGiuseppe Musumeci (Cuneo)

PAST PRESIDENT & GISE FOUNDATION ONLUS PRESIDENTSergio Berti (Massa)

38th GISE NATIONAL CONGRESS PRESIDENTAlfredo Marchese (Bari)

Alessio La Manna (Catania)Ugo Limbruno (Grosseto)Alfredo Marchese (Bari)

Ciro Mauro (Napoli)Fabio Tarantino (Forlì)

Ferdinando Varbella (Rivoli)

NURSE & TECHNICIAN PRESIDENTBeatrice Magro (Rovigo)

NURSE & TECHNICIAN PAST PRESIDENTLorenzo Ciarma (Bologna)

22 33

10 O

CTO

BER

201

7


ROOM BLUE 1 IMPROVE YOUR SKILLS 14.30 TAVI IN BICUSPID AORTIC STENOSIS15.30 14.30 Clinical case: a case of bicuspid aortic valve treated with a

self-expandable valve14.35 My tips & tricks

14.45 Clinical case: A case of BAV treated with a balloon expandable valve 14.50 My tips & tricks 15.00 Clinical case: A case of BAV treated with a mechanical controlled release valve 15.05 My tips & tricks

15.15 Discussion with the experts

15.30 MASTERING CALCIFIED LESIONS16.30

15.30 Clinical case: Intracoronary imaging / alternative: ELCA 15.35 My Tips & Tricks for imaging in calcified lesions

15.45 Clinical case: Cutting- and scoring-balloons15.50 My Tips & Tricks for use of dedicated balloons to crack calcium

16.00 Clinical case: Extreme rotablator case16.05 My Tips & Tricks for rotational atherectomy

16.15 Discussion with experts

4 5

10 OCTO

BER 2017


ROOM BLUE 2 COMPLEX SCENARIOS

14.30 NEW FRONTIERS TO START UP IN CORONARY INTERVENTIONS15.30

14.30 Clinical case start up: A drug-coated scoring balloon for coronary use

14.50 Clinical case start up: Does a stent with biodegradable polymer change the clinical outcome? Results from the DESSOLVE III study

15.10 Clinical case start up: A novel device to reduce infarct size during primary PCI

15.30 TAVI AND CORONARY ARTERY DISEASE16.30

15.30 Clinical case: Should we treat coronary lesions before TAVI?

15.50 Clinical case: Functional evaluation of coronary lesions in patients with aortic stenosis

16.10 Clinical case: Coronary protection during TAVI

ROOM YELLOW 1 EXPERT TALKS

14.30 SYMPOSIUM GISE-WOMAN PERSPECTIVE15.30 14.30 Gender-based cardiovascular risk factors: recognition, awareness and prevention

14.39 Non-atherosclerotic myocardial infarction in women: SCAD, from diagnosis to treatment

14.48 Bleeding and vascular complications: the dark side of the structural interventional procedures in women: what do we learn from the study WIN TAVI a one year

14.57 Equal opportunity: workforce distribution in the cath lab. A glance in the Women EAPCI survey

15.06 Women and heart: gender differences or lack of attention to the specificity?

15.15 Experts roundtable

4 5

10 O

CTO

BER

201

7



15.30 BVS ROUNDTABLE: THE PSP PANACEA16.30

15.30 Lecture: BRS@long-term: an unfulfilled promise? 15.39 Lecture: Insights into BRS thrombosis

15.48 Lecture: BVS in long / diffuse lesions: IT-DISAPPEARS

15.57 Lecture: BVS in complex lesions: STEMI

16.06 Lecture: BRS: what’s behind the corner


ROOM YELLOW 2 CLINICAL CROSSROADS

14.30 RADIAL NO LIMITS!15.30

14.30 Case presentation: CTO double radial approach

14.35 Lecture: Radial exposure and AKI: data from MATRIX trial

14.45 Lecture: A guide to radial CTO procedure

14.55 Case conclusion


15.30 COMBINED STRUCTURAL INTERVENTIONS16.30

15.30 Case presentation

15.35 Lecture: TAVI + LAA: what rationale?

15.45 Lecture: TAVI + Mitral: what rationale?



6 7

10 OCTO

BER 2017


ROOM ORANGE 1 TUTORIAL AND UPGRADE

14.30 CHRONIC TOTAL OCCLUSIONS FROM A TO Z15.30 Case 1: Starting antegrade and ending retrograde

Case 2: Starting retrograde and ending antegrade

Expert Lecture: How to make successful a CTO procedure

15.30 CORONARY IMAGING 16.30 Case 1: IVUS clinical case

Case 2: OCT clinical case

Expert lecture: Use of intravascular Imaging to guide our coronary procedures in daily practice

ROOM SILVER

16.30 18.15 RATIONAL CHOICES ARE BASED ON KNOWLEDGE

16.30 Present and future of the Italian National Health Service

16.45 Health Technology Assessment in Italy

17.00 Big Data, Good Data and Value-Based Medicine

17.15 Management of Devices in a budgeting world...

17.30 Technologies, clinical data and administrative choices

17.45 … at the patient’s bedside

18.00 Discussion

18.15 GISE ANNUAL MEETING20.00

6 7

10 O

CTO

BER

201

7


ROOM WHITE 114.30 ORAL COMMUNICATIONS15.20

15.20 ORAL COMMUNICATIONS16.30

ROOM WHITE 214.30 CLINICAL CASES 15.30

15.30 CLINICAL CASES 16.30

8 9

11 OCTO

BER 2017


ROOM SILVER08.00 LIVE CASES09.20

08.00 From Ragusa 08.40 From Verona

09.20 OPENING CEREMONY10.00 Welcome from President of GISE Welcome from President of FIC Welcome from President of EAPCI Welcome from PCR

10.00 LIVE CASES 11.20

10.00 From Ragusa 10.40 From Verona

11.20 MAIN SYMPOSIUM GISE-EAPCI-PCR12.40 40 YEARS OF ANGIOPLASTY: “KNOW THE PAST, IMPROVE THE PRESENT AND GET THE

FUTURE BRIGHT”

11.20 Introduction

11.25 Lecture: A 40-years long journey: looking back to move forward

11.37 Lecture: Percutaneous revascularization in stable coronary artery disease: where do we stand versus contemporary medical therapy and best available surgical practice?

11.49 Lecture: ST-elevation myocardial infarction in patients with multivessel disease: from incomplete to reasonably complete revascularization

12.01 Lecture: Percutaneous aortic valve implantation: where do we stand, what’s coming up

12.13 Lecture: Beyond TAVI: the present and the future of structural heart interventions

12.25 Discussion

12.40 LIVE IN THE BOX13.25

8 9

11 O

CTO

BER

201

7


ROOM BLUE 1 IMPROVE YOUR SKILLS

15.00 COMPLICATIONS AND TROUBLESHOOTING16.10

15.00 Clinical case: Coronary perforation 15.05 My tips&tricks to treat coronary perforation

15.15 Clinical case: Jeez! I have lost my stent … 15.20 My tips and tricks for stent retrival

15.30 Clinical case: Stent underexpansion15.35 My tips and tricks: prevention and management of stent underexpansion


16.10 CHALLENGING SETTINGS IN TRANSCATHETER MITRAL REPAIR17.20 16.10 Clinical case: A difficult trans-septal puncture and a long story afterwards 16.15 My tips&tricks

16.25 Clinical case: Grasping a large coaptation gap 16.30 My tips&tricks

16.40 Clinical case start-up: Mitral valve repair annuloplasty ring


17.20 MANAGING PATIENTS AT HIGH-BLEEDING RISK18.30

17.20 Clinical case: Polymer-free DES17.25 My tips&tricks for stenting in patients at high bleeding risk

17.35 Clinical case: Bioresorbable-polymer DES 17.40 My tips&tricks for use of BP-DES

17.50 Clinical case: Drug-eluting balloon17.55 My tips&tricks for DEB in de novo lesions


10 11

11 OCTO

BER 2017


ROOM BLUE 2 COMPLEX SCENARIOS 15.00 HEART RATE CONTROL AFTER PCI (RITMO GISE PROJECT)16.10

15.00 Clinical case: Incomplete revascularization

15.23 Clinical case: Patient with LV dysfunction and incomplete revascularisation

15.46 Clinical case: Residual ischemia

16.10 CHIP: COMPLEX, HIGH-RISK (AND INDICATED) PCI17.20

16.10 Clinical case: Left main PCI in poor LV function

16.30 Clinical case: Last remaining vessel

16.50 Clinical case: Unfavourable anatomy for the surgeon

17.10 Start-up lecture: a dedicated, self-apposing stent for the left main: from MATISSE to TRUNC

17.20 FUNCTIONAL MITRAL REGURGITATION18.30

17.20 Clinical case: Edge-to-edge repair in a patient with severe end-stage cardiomyopathy

17.43 Clinical case: Percutaneous coronary sinus-based mitral valve repair

18.06 Clinical case: The case for percutaneous mitral annuloplasty

10 11

11 O

CTO

BER

201

7



15.00 UPDATE ON SECONDARY CARDIOVASCULAR PREVENTION STRATEGIES 16.10 (Joint Symposium GISE-ANMCO)

15.00 Consensus Document GISE: Follow-Up after Coronary Stenting

15.10 New paradigms on DAPT duration in patients with ACS

15.20 Anti-ischemic drugs for the treatment of myocardial ischemia

15.30 Role of ezetimibe in cardiovascular prevention: how to “improve” clinical outcomes

15.40 The role of PCSK9 inhibition in cardiovascular prevention


16.10 STRUCTURAL HEART DISEASE IN 2017: REALITIES AND CONTROVERSIES 17.20 (Joint Symposium GISE-SICCH)

16.10 Performing TAVI in low-risk patients: are we ready? Interventionalist’s perspective

16.20 Performing TAVI in low-risk patients: are we ready? Surgeon’s perspective

16.30 The anaesthesiologist’s perspective

16.40 Heart-Team inside and outside the Cath Lab

16.50 What about mitral interventions: the Latin position


17.20 START-UP SESSION18.30

17.20 START UP: a new sheathless radial access device

17.30 START UP: a new DES for the treatment of very complex coronary lesions

17.40 START UP: an egg to protect the body in the cath lab

17.50 START UP: extravascular reabsorbable femoral closure device

18.00 START UP: 3rd generation of drug coated balloon for peripheral use

18.10 START UP: A new frontier for the interventional treatment of massive pulmonary embolism

18.20 Expert roundtable

12 13

11 OCTO

BER 2017



15.00 CTO RECANALIZATION: MAKING THE RIGHT DECISION16.10 15.00 Case presentation

15.05 Lecture: The case for CTO recanalization: we have enough evidence!

15.15 Lecture: Who does and who does not deserve a CTO procedure?

15.25 Lecture: Long-term outcome after CTO recanalization



16.10 HOW TO TREAT PATIENTS WITH HYPERSENSITIVITY TO ACETYLSALICYLIC ACID 17.20 UNDERGOING PCI


16.15 Lecture: A rapid desensitization procedure is necessary

16.25 Lecture: A single antiplatelet therapy with prasugrel or ticagrelor is sufficient

16.35 Lecture: Cangrelor during PCI and desensitization after procedure is the right solution



17.20 ANTITHROMBOTIC STRATEGIES AFTER TAVI 18.30


17.25 Lecture: Single, double, triple antithrombotic therapy after TAVI: what do we know?

17.35 Lecture: NOAC after TAVI, what do we know?

17.45 Lecture: How to deal with leaflets thickening: from diagnosis to treatment



12 13

11 O

CTO

BER

201

7



15.00 PERFORMING SIMPLIFIED TAVI 16.10 Case 1: Pre and intraprocedural approach to difficult sizing

Case 2: Transfemoral TAVI in complex vascular anatomy

Expert Lecture: How to make TAVI a safe and predictable procedure

16.10 TUTORIAL AND UPGRADE:17.20 MASTERING BIFURCATIONS

Case 1: Provisional stenting: POT, POT-side-POT, KB…

Case 2: Evaluation and management of side-branch compromise

Expert Lecture: How to approach bifurcations: a compendium

17.20 GISE CLINICAL TRIALS AND REGISTRIES18.30

17.20 SCOPE

17.30 RAD MATRIX (radiations)

17.40 APACHE

17.50 Post-PCI

18.00 IT-Disappears


14 15

11 OCTO

BER 2017


15

ROOM ORANGE 2 15.00 LIVE IN THE BOX15.45 CASE ROOM

15.45 CLINICAL CASES16.10

IMPROVE YOUR SKILLS

16.10 PFO TREATMENT17.20

16.10 Clinical case: PFO closure step-by-step 16.20 My tips&tricks

16.30 International PFO consensus Document

16.40 Case PFO

16.50 PFO closure without implant - The clinical benefits of suture based closure


17.20 SAS 2: PERIOPERATIVE ANTITHROMBOTIC MANAGEMENT18.30 OF PATIENTS WITH CORONARY STENTS UNDERGOING SURGERY

17.20 From the SAS 2 document to MONET Registry

17.35 Bridging antiplatelet therapy with Cangrelor and MONET sub-study

17.50 SAS 2: THE SURGEON’S VIEW

18.00 Clinical Case with App SAS 2


ROOM WHITE 115.00 ORAL COMMUNICATIONS18.30


14 15

11 O

CTO

BER

201

7


15

ROOM RED 2 CASE-BASED PLENARY

FOCUS ADVANCED LEARNING

15.00 FEMORAL ACCESS AND CLOSURE FOR TAVI16.30

PLENARY FOCUS ADVANCED LEARNING

16.55 BEST PRACTICE FOR ACUTE STROKE INTERVENTIONS18.25

ROOM YELLOW 3 LEARNING

FOCUS ESSENTIAL LEARNING

15.00 ESSENTIAL LEARNING ON SFA (PART 1)16.30

LEARNING FOCUS ESSENTIAL LEARNING

16.55 ESSENTIAL LEARNING ON ILIAC (PART 1)18.25

16 17

12 OCTO

BER 2017


ROOM SILVER08.00 LIVE CASES09.20

08.00 From Chieti

08.40 From Ferrara

09.20 Lecture - The management of multivessel disease in diabetics: CABG vs PCI


09.35 From Chieti

10.15 From Ferrara

BURNING DEBATES

11.00 MV DISEASE IN DM11.22

11.00 We are ready! We can treat with PCI everybody irrespective of Syntax score

11.07 No way! We can treat only low-intermediate complexity patients (Syntax <33)

11.14 Discussion and vote

11.22 THE LONG-TERM DAPT FOR SECONDARY PREVENTION IN MI PATIENTS12.25

11.22 The benefit of ticagrelor and aspirin at long-term is too low, we can use long term clopidogrel in most patients

11.29 The benefit of ticagrelor and aspirin at long-term is relevant, it is appropriate to continue in most patients


16 17

12 O

CTO

BER

201

7


ROOM SILVER BURNING DEBATES

11.44 IS IT TIME TO PERFORM TAVI IN ALL ELDERLY PATIENTS (> 80)?12.06

11.44 Go for TAVI regardless surgical risk

11.51 When feasible, surgery is still the gold standard


12.06 THE OPTIMAL MANAGEMENT OF AF AND PCI WITH HIGH-BLEEDING RISK12.30

12.06 Triple therapy and dedicated stent

12.13 Dual therapy is the right choice


12.30 LECTURE12.45 How low can you go? Aggressive LDL lowering therapy can improve the prognosis

12.45 CLINICAL TRACKS13.25

12.45 Different twins

13.05 Simple and complex

18 19

12 OCTO

BER 2017


ROOM BLUE 1 IMPROVE YOUR SKILLS

15.00 LEFT ATRIAL APPENDAGE CLOSURE16.10

15.00 Clinical case: A case of closure of a multi lobed left atrial appendage 15.05 My tips&tricks

15.15 Clinical case: A case of closure of a very large and short left atrial appendage 15.20 My tips&tricks

15.30 Start up: A totally repositionable LAA occluder


16.10 ANATOMIC AND FUNCTIONAL ASSESSMENT OF CAD17.20

16.10 FFR clinical case16.15 My tips&tricks

16.25 iFR clinical case16.30 My tips&tricks

16.40 OCT/IVUS clinical case16.45 My tips&tricks


17.20 EAPCI YOUNG/GISE YOUNG JOINT SESSION18.30 HOT TOPICS IN INTERVENTIONAL CARDIOLOGY: MEET THE EXPERTS

17.20 Clinical case: Left main PCI 17.25 My tips&tricks

17.35 Clinical case: Coronary functional evaluation 17.40 My tips&tricks

17.50 Clinical case: TAVI in an intermediate risk patient17.55 My tips&tricks

18.05 Roundtable

18 19

12 O

CTO

BER

201

7


ROOM BLUE 2 15.00 JOINT MEETING GISE - MITRAL ACADEMY 16.10 FINDING A WAY AND SHARING SOLUTIONS

15.00 Multiple percutaneous valve interventions: combined mitral and aortic valve disease

15.10 Percutaneous treatment of functional severe mitral regurgitation: how to plan the perfect road trip

15.20 Tricuspid regurgitation: surgical and transcatheter options

15.30 Mitral valve surgery: toward 100% minimally invasive repair

15.40 Mitral transcatheter therapies: the surgical point of view


COMPLEX SCENARIOS

16.10 COMPLEX CTO AND DEDICATED DEVICE17.20

16.10 Clinical case: Dedicated device for a complex CTO

16.33 Clinical case: Complex anterograde approach

16.56 Clinical case: Complex retrograde approach

17.20 POST-MI CLINICAL CASES CHALLENGE 18.30

17.20 Clinical case 1



20 21

12 OCTO

BER 2017



15.00 TAVI 2017: MAKING THE CASE FOR NEW PATIENT SUBSETS16.10 (Joint Symposium GISE-SIC)

15.00 Enlarging anatomical TAVI arena: from very small to very large annuli

15.10 Aortic valve stenosis with associated mitral valve regurgitation: is it time for combined percutaneous treatment?

15.20 TAVI and aortic regurgitation

15.30 Moderate aortic stenosis and congestive heart failure

15.40 One valve for every season or a niche for each


16.10 UPDATE ON THE ANTITHROMBOTIC THERAPY FOR PATIENTS UNDERGOING PCI17.20 16.10 Optimal duration of dual antiplatelet therapy: the ANMCO/SICI-GISE consensus document

16.20 Antithrombotic treatment in elderly patients with ACS: the SICI-GISE consensus document

16.30 The dilemma of pre-treatment in NSTE-ACS: the DUBIUS trial

16.40 The conundrum of antithrombotic treatment for atrial fibrillation in patients requiring PCI

16.50 Cangrelor: ready for prime time?


17.20 STEMI AND PPCI IN 201718.30

17.20 Lecture: Multivessel PCI: the evidence is there

17.30 Lecture: GPIIb/IIIa inhibitors are still the best solution

17.40 Lecture: Intravenous P2Y12 receptor inhibitor are the new best option

17.50 Lecture: Stent choice and implantation technique in PPCI

18.00 Lecture: Cardiogenic shock: from IABP to ECMO


20 21

12 O

CTO

BER

201

7



15.00 COMPLEX BRS PROCEDURES16.10 15.00 Case presentation

15.05 Lecture: Use BVS, just do it properly!

15.15 Lecture: This is a perfect case for a metallic BRS

15.25 Lecture: A new generation BRS



16.10 THE FASTEST AND EFFECTIVE ANTITHROMBOTIC TREATMENT FOR PRIMARY PCI17.20 16.10 Case presentation

16.15 Lecture: GPI bolus

16.25 Lecture: Cangrelor

16.35 Lecture: Ticagrelor or prasugrel alone are sufficient



17.20 THE OPTIMAL MANAGEMENT OF A PATIENT WITH AF WITH HIGH-BLEEDING RISK 18.30


17.25 Lecture: NOACs are still an option

17.35 Lecture: LAA closure with long-term aspirin is the best option

17.45 Lecture: LAA closure without long-term aspirin is the best option



22 23

12 OCTO

BER 2017


23

ROOM WHITE 1 COMPLEX SCENARIOS

15.00 ISR IS ALIVE AND, SOMETHIMES, KICKING HARD!16.10

15.00 Clinical case: Multiple recurrent ISR (DEB)

15.23 Clinical case: How drug coated balloons work

15.46 Clinical case: ISR CTO

16.10 ORAL COMMUNICATIONS18.30


16.10 GISE YOUNG 17.00

17.00 DEALING WITH NIGHTMARES18.30

17.00 Case 1

17.15 Case 2

17.30 Case 3

17.45 Case 4

18.00 Case 5

18.15 Case 6

22 23

12 O

CTO

BER

201

7


23


15.00 HF FOR INTERVENTIONALIST 16.10 UNMET NEEDS TO IMPROVE OUTCOME IN HEMODYNAMICALLY COMPROMISED PATIENTS

From high risk attempt to protected PCI standard

From hemodynamic unloading in cardiogenic shock to heart recovery

Optimizing outcomes with a multi-professional shock team: think Global - Act local

Case 1: A case managed with micro-axial percutaneous left ventricular assist device

Case 2: A case managed with ECMO

16.10 EDGE TO EDGE MITRAL REPAIR17.20 Case 1: Functional mitral regurgitation

Case 2: Organic mitral regurgitation

Expert Lecture: Edge to edge mitral repair in 2017: from planning to result optimization

17.20 FUNCTIONAL ASSESSMENT OF CAD18.30 Case 1: FFR-guided PCI

Case 2: iFR guided PCI

Expert Lecture: FFR/iFR future after FUTURE, DEFINE-FLAIR and IFR-SWEDEHEART

24 25

12 OCTO

BER 2017


ROOM ORANGE 2 15.00 LIVE IN THE BOX15.45 CASE ROOM

15.45 CLINICAL CASES16.10

COMPLEX SCENARIOS

16.10 CTO AND COMPLEX MULTIVESSEL CORONARY ARTERY DISEASE17.20

16.10 Clinical case: LM CTO with LVAD (ECMO) 16.33 Clinical case: MV with double CTO 16.56 Clinical case: complex primary PCI

17.20 UNUSUAL SCENARIOS AND IMAGING IN THE CATH LAB18.30

17.20 Clinical case: Spontaneous coronary artery dissection managed with imaging

17.43 Clinical case: ACS due to complicated coronary aneurysm

18.06 Clinical case: High thrombus burden and high-bleeding risk

24 25

12 O

CTO

BER

201

7


ROOM RED 2 LIVE DEMONSTRATION

FOCUS ADVANCED LEARNING

08.30 BIFURCATION CTO AORTOILIAC10.00

LIVE DEMONSTRATION FOCUS ADVANCED LEARNING

10.10 BIFURCATION CTO BTK11.40


11.50 BIFURCATION CTO OSTIAL SFA13.20


15.00 COMPLEX CAROTID16.30

CASE-BASED PLENARY FOCUS ADVANCED LEARNING

16.45 CRITICAL LIMB ISCHAEMIA AND COMPLICATIONS18.15

26 27

12 OCTO

BER 2017


27

ROOM YELLOW 3 LEARNING

FOCUS ESSENTIAL LEARNING

08.30 ESSENTIAL LEARNING ON SFA (PART 2)10.00


10.10 ESSENTIAL LEARNING ON CAROTID11.40


11.50 ESSENTIAL LEARNING ON ILIAC (PART 2)13.20

CASES FOCUS ESSENTIAL LEARNING

15.00 COMPLICATIONS ILIAC AND SFA16.30

CASES FOCUS ESSENTIAL LEARNING

16.45 COMPLICATIONS CAROTID18.15

26 2727

13 O

CTO

BER

201

7


ROOM SILVER08.00 LIVE CASES 09.15

08.00 From Naples

EVIDENCE-PRACTICE MISMATCH

09.15 FFR IN MULTIVESSEL DISEASE09.31 What guidelines suggest: FFR recommendations are based on solid rock

What real world registries show: why FFR penetration is so low?

09.31 TAVI FOR LOW RISK PATIENTS09.55 What guidelines suggest What real world registries show

How to select the appropriate THV

09.55 RETREATMENT IN ACS 10.19 What guidelines suggest

What real world registries show

Personalized antiplatelet therapy with P2Y12 receptor inhibitors: in the modern era

10.19 COMPLEX AND HIGH-RISK PATIENTS10.44 Intra-aorticballoonpumpincardiogenicshock

Micro-axialpercutaneousleftventricularassistdevice:clinicalcaseandcurrentevidences

Percutaneoustreatmentofrefractoryangina:anewtherapeuticoption

10.44 Expertsroundtable11.05

28 29

13 OCTO

BER 2017


ROOM SILVER11.05 CLINICAL CASES COMPETITION AND GISE AWARDS11.50


11.50 From Naples

13.10 CLOSING REMARKS AND ELECTORAL RESULTS13.30

38°

Nat

iona

l Con

gres

s It

alia

n So

ciet

y of

Inte

rven

tion

al C

ardi

olog

y -

10 -

13

Oct

ober

201

7 M

iCo

Cong

ress

Cen

tre

Mila

no -

Ital

y

SCIENTIFIC SECRETARIAT

Via Conservatorio, 2220122 Milano

Tel. +39 02 77297541 Fax +39 02 [email protected]

www.gise.it

SCIENTIFIC SECRETARIAT

19, allées Jean Jaurès, BP 61508 31 015 Toulouse cedex 6, France

Tel. +33 (0)5 34 45 26 45 Fax +33 (0)5 61 42 00 09

[email protected] www.pcronline.com

ORGANISING SECRETARIAT

meetingspecialists

Viale G. Matteotti, 750121 Firenze

Tel. +39 055 50351 Fax +39 055 5001912

[email protected]

national congress 10 - 13 october 2017 mico congress ... · 10 - 13 october 2017 mico congress...

Documents